D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.27% |
| 2 | Consumer Discretionary | 9.91% |
| 3 | Healthcare | 7.11% |
| 4 | Financials | 6.94% |
| 5 | Communication Services | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Biogen
BIIB
$29.9B
| $107M | 0.1% |
376,491
-413,202
| -52% | -$135M |
|
202
MetLife
MET
$61B
| $107M | 0.1% |
1,725,403
+1,017,932
| +144% | +$61.3M |
|
203
Cloudflare
NET
$93B
| $106M | 0.1% |
945,279
+203,409
| +27% | +$24.3M |
|
204
Spotify
SPOT
$99.2B
| $106M | 0.1% |
471,468
+288,928
| +158% | +$68.1M |
|
|
205
CALL
Apple
AAPL
$4.89T
| $106M | 0.1% |
749,900
-210,900
| -22% | -$31M |
|
206
Stanley Black & Decker
SWK
$14.2B
| $106M | 0.1% |
603,912
-17,489
| -3% | -$3.41M |
|
207
PUT
HubSpot
HUBS
$10.5B
| $105M | 0.1% |
156,000
+51,000
| +49% | +$32.9M |
|
208
CALL
Visa
V
$677B
| $105M | 0.1% |
472,500
-28,200
| -6% | -$6.61M |
|
209
CALL
ExxonMobil
XOM
$651B
| $105M | 0.1% |
1,789,100
+142,000
| +9% | +$8.09M |
|
210
Lyft
LYFT
$5.39B
| $105M | 0.09% |
1,961,558
+417,046
| +27% | +$22.1M |
|
211
Lockheed Martin
LMT
$134B
| $105M | 0.09% |
303,860
-119,581
| -28% | -$43.3M |
|
|
DOCU
212
PUT
DocuSign
DOCU
$9.63B
| $104M | 0.09% |
405,900
-6,000
| -1% | -$1.73M |
|
213
Range Resources
RRC
$9.11B
| $104M | 0.09% |
4,605,708
+20,254
| +0.4% | +$328K |
|
214
Regeneron Pharmaceuticals
REGN
$68.8B
| $104M | 0.09% |
172,135
+119,119
| +225% | +$74M |
|
215
PUT
ASML
ASML
$675B
| $104M | 0.09% |
139,500
+61,800
| +80% | +$48.6M |
|
|
DISCK
216
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $104M | 0.09% |
4,271,354
-1,423,033
| -25% | -$38M |
|
217
American Express
AXP
$223B
| $103M | 0.09% |
616,913
+554,377
| +886% | +$92.7M |
|
218
CALL
Adobe
ADBE
$89.5B
| $103M | 0.09% |
178,800
-21,400
| -11% | -$13.5M |
|
219
Carvana
CVNA
$43.3B
| $102M | 0.09% |
1,697,025
+7,785
| +0.5% | +$518K |
|
220
PUT
JPMorgan Chase
JPM
$939B
| $102M | 0.09% |
621,400
-193,000
| -24% | -$30.3M |
|
221
Capital One
COF
$124B
| $101M | 0.09% |
624,300
+269,961
| +76% | +$44.1M |
|
|
XYZ
222
Block Inc
XYZ
$45.9B
| $101M | 0.09% |
420,941
-1,261,713
| -75% | -$324M |
|
223
CALL
Moderna
MRNA
$21.5B
| $101M | 0.09% |
261,900
-100,800
| -28% | -$37.2M |
|
224
Goldman Sachs
GS
$313B
| $100M | 0.09% |
265,004
+58,639
| +28% | +$22.9M |
|
225
Zimmer Biomet
ZBH
$17.7B
| $100M | 0.09% |
704,007
-258,141
| -27% | -$38M |
|
Similar funds
D.E. Shaw & Co's Q3 2021 Portfolio in Review
As of Q3 2021, D.E. Shaw & Co held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
D.E. Shaw & Co withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Sea Limited worth $206M.
- D.E. Shaw & Co's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- D.E. Shaw & Co added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- D.E. Shaw & Co's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- D.E. Shaw & Co fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- D.E. Shaw & Co's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- D.E. Shaw & Co opened 915 new positions and closed 695 in Q3 2021.
- D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.